Back to search

Article

Proteomic analysis reveals complex interactions between PERK/ISR and MAPK1 in translational control in a phenotypic toxin model of Parkinson’s disease expressing PINTAC peptides

2024-12-17

Abstract excerpt

In a proteomics investigation of a Parkinson’s disease [PD] cell model, a panel of 7 proprietary PINTAC peptides deployed in an in vitro phenotypic screen in SH-SY5Y cells treated with 6-OHDA identified 2 shorter variants of PERK protein kinase. One of the PERK variants, which is SUMOylated, associates in vitro with phosphorylated EIF2 alpha and its ubiquitinated isoforms, which also involves another PERK substr...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
43be9b1b-1b15-5e2c-9c7a-fd4d56aa5a28
DOI
10.1101/2024.12.14.628501
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Proteomic analysis reveals complex interactions between PERK/ISR and MAPK1 in translational control in a phenotypic toxin model of Parkinson’s disease expressing PINTAC peptidesDOI 10.1101/2024.12.14.628501
Select a neighboring publication to make it the new centre.